In addition, BRCA1/2, ATM, BRIP1, PALB2, RAD51C, and RAD51D gene mutations are reported to be associated with high risk of ovarian cancers, and from the results of tumor tissue, it is easy to further determine their genetic status. The gene discussed is PALB2; the disease is neoplasm.